Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Gastroenterology Reports
Published in: Current Gastroenterology Reports 9/2015

01-09-2015 | Pediatric Gastroenterology (S Orenstein, Section Editor)

The Kidney in Pediatric Liver Disease

Authors: Robyn Greenfield Matloff, Ronen Arnon

Published in: Current Gastroenterology Reports | Issue 9/2015

Login to get access

Abstract

There is an intricate relationship between the liver and the kidney, with renal physiology and function intimately involved in many primary disorders of pediatric liver disease. The hemodynamic changes of progressive cirrhosis affect and are directly affected by changes in renal blood flow and renal handling of sodium and free water excretion. Resulting complications of worsening ascites, hyponatremia, and acute kidney injury frequently complicate the care of children with advanced liver disease and contribute significant morbidity and mortality. While liver transplantation may restore hemodynamic stability, nearly 40 % of pediatric liver transplant recipients develop chronic kidney disease post-transplant and approximately 25 % are left with clinical hypertension. This review seeks to provide a basic understanding of this relationship to enable the provision of optimal care to children with liver disease.
Literature
1.
Planas R, Montoliu S, Ballesté B, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4:1385–94.CrossRefPubMed
2.••
Pugliese R, Fonseca EA, Porta G, et al. Ascites and serum sodium are markers of increased waiting list mortality in children with chronic liver failure. Hepatology. 2014;59:1964–71. Large scale study evaluating the relationship of hyponatremia and morbidity in children awaiting liver transplantation. CrossRefPubMed
3.
Ginès P, Fernández-Esparrach G, Arroyo V, et al. Pathogenesis of ascites in cirrhosis. Semin Liver Dis. 1997;17:175–89.CrossRefPubMed
4.
Ros J, Jiménez W, Lamas S, et al. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology. 1995;21:554–60.PubMed
5.
Guarner C, Soriano G, Tomas A, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology. 1993;18:1139–43.CrossRefPubMed
6.
Henriksen JH, Bendtsen F, Gerbes AL, et al. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor. Hepatology. 1992;16:1163–70.CrossRefPubMed
7.
Arroyo V, Bosch J, Gaya-Beltrán J, et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med. 1981;94:198–201.CrossRefPubMed
8.
Ginés P, Berl T, Bernardi M, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology. 1998;28:851–64.CrossRefPubMed
9.
Angeli P, Wong F, Watson H, et al. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology. 2006;44:1535–42.CrossRefPubMed
10.
Carey RG, Bucuvalas JC, Balistreri WF, et al. Hyponatremia increases mortality in pediatric patients listed for liver transplantation. Pediatr Transplant. 2010;14:115–20.CrossRefPubMed
11.
Ling SC, Avitzur Y. Predicting outcomes for children awaiting liver transplantation: is serum sodium the answer? Hepatology. 2014;59:1678–80.CrossRefPubMed
12.
Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. 2005;41:32–9.CrossRefPubMed
13.
Rodríguez MJ, Alcaraz A, Solana MJ, et al. Neurological symptoms in hospitalised patients: do we assess hyponatraemia with sufficient care? Acta Paediatr. 2014;103:e7–e10.CrossRefPubMed
14.
Solà E, Ginès P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol. 2010;53:1135–45.CrossRefPubMed
15.
Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–3.CrossRefPubMed
16.
Ramaccioni V, Soriano HE, Arumugam R, et al. Nutritional aspects of chronic liver disease and liver transplantation in children. J Pediatr Gastroenterol Nutr. 2000;30:361–7.CrossRefPubMed
17.
Lee J, Kim DK, Lee JW, et al. Rapid correction rate of hyponatremia as an independent risk factor for neurological complication following liver transplantation. Tohoku J Exp Med. 2013;229:97–105.CrossRefPubMed
18.
Wu CC, Yeung LK, Tsai WS, et al. Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis. Clin Nephrol. 2006;65:28–33.CrossRefPubMed
19.
Goldstein SL. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif. 2012;33:131–7.CrossRefPubMed
20.
Mammen C, Al Abbas A, Skippen P, et al. Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis. 2012;59:523–30.CrossRefPubMed
21.
Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365–70.CrossRefPubMed
22.
Abstract. Kidney Int Suppl (2011) 2012;2:6.
23.
Matloff RG, Arnon R, Saland JM. The kidney in pediatric liver transplantation: an updated perspective. Pediatr Transplant. 2012;16:818–28.CrossRefPubMed
24.
Francoz C, Glotz D, Moreau R, et al. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol. 2010;52:605–13.CrossRefPubMed
25.••
Angeli P, Ginès P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol 2015 Updated guidelines for the management of AKI in cirrhosis.
26.•
Fortenberry JD, Paden ML, Goldstein SL. Acute kidney injury in children: an update on diagnosis and treatment. Pediatr Clin North Am. 2013;60:669–88. Important review of AKI in children. CrossRefPubMed
27.
Price JF, Mott AR, Dickerson HA, et al. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med. 2008;9:279–84.CrossRefPubMed
28.
Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151–7.CrossRefPubMed
29.
Wiest R, Das S, Cadelina G, et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest. 1999;104:1223–33.CrossRefPubMedPubMedCentral
30.
Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197–209.CrossRefPubMed
31.
Salerno F, Gerbes A, Ginès P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Postgrad Med J. 2008;84:662–70.CrossRefPubMed
32.
Ruiz-del-Arbol L, Monescillo A, Arocena C, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42:439–47.CrossRefPubMed
33.
Ruiz-del-Arbol L, Urman J, Fernández J, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 2003;38:1210–8.CrossRefPubMed
34.
Belcher JM, Sanyal AJ, Peixoto AJ, et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology. 2014;60:622–32.CrossRefPubMedPubMedCentral
35.
Bozanich NK, Kwo PY. Renal insufficiency in the patient with chronic liver disease. Clin Liver Dis. 2015;19:45–56.CrossRefPubMed
36.
Fernandez-Seara J, Prieto J, Quiroga J, et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 1989;97:1304–12.PubMed
37.
Maroto A, Ginès P, Arroyo V, et al. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction. Hepatology. 1993;17:788–93.PubMed
38.
Sacerdoti D, Bolognesi M, Merkel C, et al. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology. 1993;17:219–24.PubMed
39.
Liver EAftSot. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.CrossRef
40.
Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 2012;61:297–310.CrossRefPubMed
41.
Israelsen ME, Gluud LL, Krag A. Acute kidney injury and hepatorenal syndrome in cirrhosis. J Gastroenterol Hepatol. 2015;30:236–43.CrossRef
42.
Salerno F, Cammà C, Enea M, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology. 2007;133:825–34.CrossRefPubMed
43.
Cochat P, Hulton SA, Acquaviva C, et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 2012;27:1729–36.CrossRefPubMed
44.
Mc Guire PJ, Lim-Melia E, Diaz GA, et al. Combined liver-kidney transplant for the management of methylmalonic aciduria: a case report and review of the literature. Mol Genet Metab. 2008;93:22–9.CrossRefPubMed
45.
Pierik LJ, van Spronsen FJ, Bijleveld CM, et al. Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up. J Inherit Metab Dis. 2005;28:871–6.CrossRefPubMed
46.
Santra S, Preece MA, Hulton SA, et al. Renal tubular function in children with tyrosinaemia type I treated with nitisinone. J Inherit Metab Dis. 2008;31:399–402.CrossRefPubMed
47.
McKiernan PJ. Nitisinone in the treatment of hereditary tyrosinaemia type 1. Drugs. 2006;66:743–50.CrossRefPubMed
48.
Sözeri E, Feist D, Ruder H, et al. Proteinuria and other renal functions in Wilson’s disease. Pediatr Nephrol. 1997;11:307–11.CrossRefPubMed
49.
Zhuang XH, Mo Y, Jiang XY, et al. Analysis of renal impairment in children with Wilson’s disease. World J Pediatr. 2008;4:102–5.CrossRefPubMed
50.
Di Stefano V, Lionetti E, Rotolo N, et al. Hypercalciuria and nephrocalcinosis as early feature of Wilson disease onset: description of a pediatric case and literature review. Hepat Mon. 2012;12:e6233.CrossRefPubMedPubMedCentral
51.
Ward CJ, Yuan D, Masyuk TV, et al. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum Mol Genet. 2003;12:2703–10.CrossRefPubMed
52.
Roy S, Dillon MJ, Trompeter RS, et al. Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors. Pediatr Nephrol. 1997;11:302–6.CrossRefPubMed
53.
Adeva M, El-Youssef M, Rossetti S, et al. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore). 2006;85:1–21.CrossRef
54.
Saner FH, Cicinnati VR, Sotiropoulos G, et al. Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation. Liver Int. 2012;32:179–88.CrossRefPubMed
55.
Nankivell BJ, Borrows RJ, Fung CL, et al. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation. 2004;78:557–65.CrossRefPubMed
56.
English J, Evan A, Houghton DC, et al. Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation. 1987;44:135–41.CrossRefPubMed
57.
Trotter JF, Grafals M, Alsina AE. Early use of renal-sparing agents in liver transplantation: a closer look. Liver Transpl. 2013;19:826–42.CrossRefPubMed
58.
Matloff RG, Diamond R, Weinberg A, et al. Biliary atresia is associated with hypertension. J Pediatr Gastroenterol Nutr 2015.
59.
Bishop JR, Burniston MT, Barnfield MC, et al. Renal function evaluated by measured GFR during follow-up in pediatric liver transplant recipients. Pediatr Transplant. 2009;13:96–103.CrossRefPubMed
60.
Harambat J, Ranchin B, Dubourg L, et al. Renal function in pediatric liver transplantation: a long-term follow-up study. Transplantation. 2008;86:1028–34.CrossRefPubMed
61.
Herlenius G, Hansson S, Krantz M, et al. Stable long-term renal function after pediatric liver transplantation. Pediatr Transplant. 2010;14:409–16.CrossRefPubMed
62.
Herzog D, Martin S, Turpin S, et al. Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. Transplantation. 2006;81:672–7.CrossRefPubMed
63.
kidne KDcpgfc. K/DOQI clinical practice guidelines for chronic kidney disease; Evaluation classification and stratification Am J Kidney Dis 2002;2(2 Supplement 1):S1-S266.
64.
65.
Kivelä JM, Räisänen-Sokolowski A, Pakarinen MP, et al. Long-term renal function in children after liver transplantation. Transplantation. 2011;91:115–20.CrossRefPubMed
66.
Brinkert F, Kemper MJ, Briem-Richter A, et al. High prevalence of renal dysfunction in children after liver transplantation: non-invasive diagnosis using a cystatin C-based equation. Nephrol Dial Transplant. 2011;26:1407–12.CrossRefPubMed
67.
Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50:169–80.CrossRefPubMed
68.
McLin VA, Anand R, Daniels SR, et al. Blood pressure elevation in long-term survivors of pediatric liver transplantation. Am J Transplant. 2012;12:183–90.CrossRefPubMed
69.
Din-Dzietham R, Liu Y, Bielo MV, et al. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116:1488–96.CrossRefPubMed
70.
Bayrakci US, Baskin E, Ozcay F, et al. Abnormal circadian blood pressure regulation in liver transplanted children. Pediatr Transplant. 2012;16:160–4.CrossRefPubMed
71.•
Flynn JT, Daniels SR, Hayman LL, et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014;63:1116–35. Guidelines for ambulatory blood pressure monitoring in children. CrossRefPubMedPubMedCentral
Metadata
Title
The Kidney in Pediatric Liver Disease
Authors
Robyn Greenfield Matloff
Ronen Arnon
Publication date
01-09-2015
Publisher
Springer US
Published in
Current Gastroenterology Reports / Issue 9/2015
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-015-0457-x

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits